Wymzya Fe Kit
Product Images NDC 68180-873

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Wymzya Fe (NDC 68180-873). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Risk Of Breast Cancer With Combined Oral Contraceptive Use (3911cc35 99a8 424c 806a 0fb6582d239a 01)

A forest plot chart displaying effect estimates (OR/RR) with 95% confidence intervals from various contraceptive studies between 2002 and 2017, comparing ever use and current use outcomes. Studies are listed on the vertical axis, and the horizontal axis measures effect estimates ranging from -1.5 to 2. The chart includes point estimates and confidence intervals for each study, showing relative risk or odds ratios around 1.0 with some variation.*

FDA Label Image

Image-1 (3911cc35 99a8 424c 806a 0fb6582d239a 02)

Chemical structure diagrams of Norethindrone and Ethinyl Estradiol are shown in the image, each labeled below the corresponding molecular structure. The diagrams depict the specific arrangement of atoms and bonds for these two active ingredients.*

FDA Label Image

Image-2 (3911cc35 99a8 424c 806a 0fb6582d239a 03)

A diagram illustrating the effectiveness of various birth control methods. It categorizes methods by approximate pregnancy rates per 100 women per year, from fewer than 1 pregnancy for implants, injections, intrauterine devices, and sterilization, to 85 or more pregnancies for no birth control. Other methods listed include birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, abstinence during fertile days, spermicide, and withdrawal.*

FDA Label Image

Image-3 (3911cc35 99a8 424c 806a 0fb6582d239a 04)

An instructional diagram showing a 28-day medication calendar layout with days of the week labeled in columns (Sunday to Saturday) and rows labeled as Week 1 to Week 4. Instructions for users on where to start taking medication based on the first day of their period are provided. A note about monthly self-breast exams is also included on the side.*

FDA Label Image

Image-4 (3911cc35 99a8 424c 806a 0fb6582d239a 05)

Packaging label for WYMZYA Fe chewable tablets 0.4 mg/0.035 mg containing norethindrone and ethinyl estradiol and ferrous fumarate. The label shows a weekly medication calendar for four weeks on the left, with daily dose markers from Sunday to Saturday, and a barcode, storage information, manufacturer Lupin Limited (India) and distributor Lupin Pharmaceuticals, Inc. (USA) on the right.*

FDA Label Image

Image-5 (3911cc35 99a8 424c 806a 0fb6582d239a 06)

WYMZYA Fe tablets packaging label by Lupin Pharmaceuticals, Inc., showing norethindrone and ethinyl estradiol chewing tablets USP combined with ferrous fumarate tablets. The strength is 0.4 mg/0.035 mg with a package containing 1 blister of 28 tablets. The label features dosage, safety information, and barcodes.*

FDA Label Image

Image-6 (3911cc35 99a8 424c 806a 0fb6582d239a 07)

Packaging label for WYMZYA Fe tablets, containing norethindrone and ethinyl estradiol USP (chewable) and ferrous fumarate tablets. The label specifies a strength of 0.4 mg/0.035 mg per tablet and indicates a package size of 3 blisters with 28 tablets each. The product is distributed by Lupin Pharmaceuticals, Inc. and manufactured by Lupin Limited in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.